Auranofin versus placebo in rheumatoid arthritis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Auranofin Versus Placebo in Rheumatoid Arthritis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437255/all/Gene_therapy_for_haemophilia:_Cochrane_systematic_review. Accessed 19 April 2024.
Auranofin versus placebo in rheumatoid arthritis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437255/all/Gene_therapy_for_haemophilia:_Cochrane_systematic_review. Accessed April 19, 2024.
Auranofin versus placebo in rheumatoid arthritis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437255/all/Gene_therapy_for_haemophilia:_Cochrane_systematic_review
Auranofin Versus Placebo in Rheumatoid Arthritis [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437255/all/Gene_therapy_for_haemophilia:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Auranofin versus placebo in rheumatoid arthritis
ID - 437255
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437255/all/Gene_therapy_for_haemophilia:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -